/ Print /

Julie Miller
Julie Miller was the former Managed Healthcare Executive Editor in Chief until May of 2014.
Enrollment numbers ease risk fears
Officials believe the risk pools are solid
Prescription trend remains modest
After a small decline in spending for 2012, trend is up just 1% per capita.
AMCP: Generic availability more important than patent expiration
In yesterday’s pipeline update, Chris Peterson, PharmD, a director in the Emerging Therapeutics department at Express Scripts, reviewed the trend in FDA approvals and noted several of the key therapeutic areas with recent generics.
[SLIDESHOW] Managed Healthcare Executive State of the Industry
Ever since the Patient Protection and Affordable Care Act was signed into law, healthcare observers from all corners of the country have made predictions on everything from the ultimate cost of health reform to the percentage of the uninsured. There’s a mix of both optimism and pessimism. 2014 will provide us an opportunity to compare their predictions to the ultimate reality.Managed Healthcare Executive polled readers on their forecast for 2014 and beyond. Nearly 350 readers responded and their feedback is summarized here in our 2014 State of the Industry slideshow.
Rate reality hard to pin down
Despite grim predictions of rate shock, older and sicker people will experience 'rate joy' in the exchanges
Why slow growth isn't really good news
Workers have their own ideas on who's getting the best deal in health coverage
State limits specialty copays
Delaware's law aims to increase access while plans manage 15% annual trend in specialty drugs
Physicians worry reform reduces fee schedule
A survey of New Jersey physicians reveals concern about reimbursement and changes to practice structures
Unauthorized prescribers bilk Part D out of $5.4 million
A recent OIG study reveals that in 2009, Medicare Part D paid $5.4 million to massage therapists, dieticians, and other individuals who clearly lacked authority to prescribe drugs